Elevance Health, Inc.

Elevance Health, Inc.

391.00
EUR
+11.40
(+3.00%)
19.60EPS
Jan 27Next Earn

Important Dates

Elevance Health, Inc.'s next confirmed earnings release is scheduled for January 27, 2027.

Earnings Date1/27/2027

Share Statistics

As of June 30, 2026, Elevance Health, Inc. has 216.84M shares outstanding.

Shares Outstanding216.84M

Financial Position

These figures are as of June 30, 2026.

Debt / Equity68.95

Financial Efficiency

EUR

Over the twelve months ended June 30, 2026, Elevance Health, Inc. posted a return on equity (ROE) of 11.20, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 4.00, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 8.25, useful for judging operating efficiency across full business cycles. The company generates approximately 1.78M in revenue per employee across its workforce of 98,875.00, a quick read on workforce productivity versus industry peers.

Return on Equity (ROE)11.20
Return on Assets (ROA)4.00
Return on Capital Employed (ROCE)8.25
Revenue Per Employee1.78M
Employee Count98,875.00

Taxes

EUR

Over the twelve months ended June 30, 2026, Elevance Health, Inc. recorded 800.90M in income tax expense. That works out to an effective tax rate of 15.61, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 5.13B, leaving 4.34B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax800.90M
Effective Tax Rate15.61

Income Statement

EUR

Over the twelve months ended June 30, 2026, Elevance Health, Inc. generated 176.03B in revenue and converted that into 4.34B in net income, yielding earnings per share of 19.60.

Revenue176.03B
Pretax Income5.13B
Net Income4.34B
Earnings Per Share (EPS)19.60

Balance Sheet

EUR

As of June 30, 2026, Elevance Health, Inc. holds 31.47B in cash and equivalents against 27.17B in total debt, resulting in a net debt position of 18.22B.

Cash & Cash Equivalents31.47B
Total Debt27.17B
Net Debt18.22B
Equity (Book Value)39.29B
Book Value Per Share181.17

Cash Flow

EUR

Elevance Health, Inc. produced 6.53B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.03B in capital expenditures, free cash flow totaled 5.50B - equivalent to 25.11 per share.

Operating Cash Flow6.53B
Capital Expenditures-1.03B
Free Cash Flow5.50B
FCF Per Share25.11

Margins

These figures cover the twelve months ended June 30, 2026.

Pretax Margin2.91
Profit Margin2.47

Dividends & Yields

EUR

Over the twelve months ended June 30, 2026, Elevance Health, Inc. paid dividends of 6.02 per share. The dividend payout ratio of 30.56 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Dividend Per Share6.02
Payout Ratio30.56

Stock Splits

Elevance Health, Inc.'s most recent stock split took place on June 1, 2005 with a 1:2 split ratio.

Last Split Date6/1/2005
Split Ratio1:2